The diagnosis of muscle wasting disorder includes blood test, x-ray test, magnetic resonance imaging, computed tomography scan, muscle biopsy, nerve conduction, and electromyography.

Albany, NY -- (SBWire) -- 02/09/2017 --The tendency of the body to lose tissue is referred as muscle wasting disorder, or muscle atrophy. Muscle atrophy can be classified as neurogenic atrophy or disuse atrophy. Disuse atrophy is caused by the lack of physical activity, whereas neurogenic atrophy occurs due to an injury or disease to a nerve that connects the muscle. While the cases of disuse atrophy is escalating due to the growing trend of sitting jobs and increasing number of people with certain medical condition that limits their movements, neurogenic atrophy is more severe and is quite prevalent too. Etiology for muscle atrophy includes amyotrophic lateral sclerosis, guillain-barre syndrome, long-term corticosteroid therapy, motor neuropathy and alcohol-associated myopathy. Some of the signs and symptoms of muscle atrophy are one arm smaller than other and patient feels physically inactive.

Request a Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=115

The diagnosis of muscle wasting disorder includes blood test, x-ray test, magnetic resonance imaging, computed tomography scan, muscle biopsy, nerve conduction, and electromyography. Along with the surging demand for these diagnosis tools, the global market for muscle wasting disorder is also benefitting from the requirement of customized exercise, physical therapy, ultrasound, and surgery. Concurrently, the global market for muscle wasting disorder is projected for a healthy growth rate during the forecast period of 2016 to 2024. This report is a comprehensive analysis of this market and is aimed at providing insights to the players and aid in decision making. One of the key feature of this report is the section on company profiles, wherein several prominent players have been explored for their market share, competitors, product portfolio, recent developments, and future strategies.

Request for TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=115

Global Muscle Wasting Disorder Market: Trends and Prospects

According to the World Health Organization (WHO), global geriatric population will rise to two billion by 2050. Since these vast population is more prone to muscle atrophy, the demand in global muscle wasting disorder is expected to swell considerably during the forecast period. Additionally, technological advancements in diagnostic test, which have become very efficient at detecting the cause, will further boost the market. However, lack of awareness among the end-users and lack of healthcare infrastructure in some of the developing nations of the world is restricting this market to expand to a vast population base.

Global Muscle Wasting Disorder Market: Geographical Outlook

High awareness pertaining to the prevalence of muscle atrophy and the availability of advanced diagnostics is the primary reason that make North America the most lucrative region in this market. Federal government in the U.S., which is the most prominent country-wide market in this region, are also taking initiatives to cure the patients and thereby favoring the uptake. Europe currently accounts for the second widest regional market, although vastly populated region of Asia Pacific is projected to expand at a higher growth rate due to the improving healthcare infrastructure. The region of rest of the world is expected to remain at fourth position, although demand is expected to slightly increase from some of the African countries.

Read Complete Report @ https://www.tmrresearch.com/muscle-wasting-disorder-market

Major market players involved in manufacturing the treatment product of muscle atrophy and contributing the global market share includes Genzyme Corporation, Pfizer, Inc., Isis Pharmaceuticals, Inc., Neurotune AG, California Stem Cell, Inc., Nexgenix Pharmaceuticals, LLC, Cellular Biomedicine Group, Inc. and Paratek Pharmaceuticals, Inc.

About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.